查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1540873

2024-2032 年按产品类型、应用类型、应用、最终用户和地区分類的脸部注射剂市场报告

Facial Injectables Market Report by Product Type, Application Type, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球脸部注射市场规模达到85亿美元。人口老化、个人对非侵入性解决方案的需求不断增长以及名人代言和社交媒体的影响推动了全球美容疗程的需求，推动了脸部注射市场的发展。

脸部注射剂市场分析：

主要市场驱动因素：对微创整容手术的需求不断增长、面部美容意识不断增强以及老年人口希望显得年轻，推动了市场增长。

主要市场趋势：由于肉毒桿菌和皮肤填充剂等非手术程序的效率和最少的停机时间，对它们的需求正在增加。在脸部注射剂市场预测中，由于人们越来越渴望获得自然效果并为患者提供有效、安全的客製化治疗，该行业将见证多样化产品配方和应用选项的不断创造。

地理趋势：由于可支配收入高、医疗基础设施发达以及美容治疗的广泛采用，北美成为最大的市场。其他潜在市场包括亚太和欧洲，这些地区居民的收入不断增加，随之而来的是严格的法规，以及数百家提供注射治疗的美容诊所。

竞争格局：脸部注射剂行业的一些主要市场参与者包括 Allergan Plc、Anika Therapeutics Inc.、Bloomage BioTechnology、Johnson & Johnson、Galderma Pharma SA、Integra LifeSciences、Ipsen (Mayroy SA)、Medytox Inc.、Merz Holding GmbH & Co Co . KG、Prollenium Medical Technologies Inc.、赛诺菲、SciVision Biotech Inc.、Sinclair Pharma（华东医药股份有限公司）、Suneva Medical Inc. 和Bausch Health Companies Inc. 等。

挑战与机会：监管障碍和安全问题给市场参与者带来了挑战，需要严格遵守品质标准并与消费者进行透明沟通。如同脸部注射市场概述中所述，向新兴经济体和男性美容手术等未开发市场的扩张，为传统细分市场竞争加剧和市场饱和提供了成长途径。

脸部注射剂市场趋势：

人口老化加剧：

随着全球人口老化，对脸部注射剂的需求不断增加。虽然它们很重要，但老化会带来各种明显的迹象，如皱纹、细纹和皮肤下垂。因此，人们总是选择美容疗程来保持年轻的外表。由于零停机时间和非手术程序，脸部注射鼓励广大受众询问如何在不接受侵入性治疗的情况下自我恢復活力。此外，已开发国家的年龄层正在扩大，人们现在更加关心自己的外表。因此，他们愿意寻求美容治疗，以达到最佳的外观和感觉，从而影响脸部注射剂的市场前景。根据世界卫生组织的数据，2020 年，全球 60 岁及以上人口超过了 5 岁以下儿童。全球老化人口预计将翻一番，从 2015 年的 12% 增加到 2050 年的 22%。

对非侵入性手术的需求不断增长

人们选择非侵入性脸部整形手术是因为其方便、停机时间短、风险低、副作用少。例如，真皮填充剂和肉毒桿菌注射剂可以为许多常见的美容问题（如皱纹、体积减少和脸部不对称）提供快速有效的解决方案。此外，忙碌的生活和技术进步使许多手术变得高效且危险性降低，影响了新一代非侵入性面部治疗，从而增加了脸部注射剂的市场价值。美国整形外科医师协会（ASPS）的数据显示，2022年美国总共进行了2,620万例手术和微创整容及重建治疗。数量。

名人代言与社群媒体影响力

美容标准和消费者偏好受到名人代言和社群媒体人物的影响，这推动了脸部注射剂市场的成长。当名人公开讨论他们的脸部整形手术或在各种社交媒体网站上发布相关资讯时，他们的追随者更有可能考虑使用脸部注射剂。例如，根据美国脸部整形与重建外科学会 (AAFPRS) 的调查，自 2019 年以来，脸部整形外科医生的整容手术增加了 90%。手术的外科医生。鼻子整形手术或鼻整形手术则位居第二，外科医师进行的手术占 79%，而眼睑整形手术或眼部整形手术则占 73%。对男女来说，前三名的外科手术是鼻整形手术，占 83%，眼睑整形术占 49%，脸部除皱和局部除皱术占 48%。

脸部注射剂市场细分：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据产品类型、应用程式类型、应用程式和最终用户对市场进行了分类。

按产品类型划分：

胶原

透明质酸 (HA)

A型肉毒桿菌毒素

羟基磷灰石钙 (CaHA)

聚甲基丙烯酸甲酯珠（PMMA微球）

聚左旋乳酸 (PLLA)

其他的

A型肉毒桿菌素占据大部分市场份额

该报告根据产品类型对市场进行了详细的细分和分析。其中包括胶原蛋白、透明质酸 (HA)、A 型肉毒桿菌毒素、羟基磷灰石钙 (CaHA)、聚甲基丙烯酸甲酯珠（PMMA 微球）、聚 L-乳酸 (PLLA) 等。根据该报告，A 型肉毒桿菌毒素占最大部分。

A 型肉毒桿菌毒素占最大份额，因为它广泛用于解决多种美容问题，包括皱纹、细纹和脸部不对称。 A 型肉毒桿菌注射（例如 Botox、Dysport 和 Xeomin）可透过放鬆脸部肌肉并确保皮肤更光滑、更年轻，提供复杂的临时解决方案。目前，消费者对微创美容手术的需求持续成长，推动了现有产品线的生产。例如，2024年3月，Croma的韩国毒素产品製造商和合作伙伴Hugel获得美国食品药物管理局批准Letybo(R)（LetibotulinumtoxinA）用于治疗成人眉间纹。

按应用程式类型细分：

美学

疗法

美学占据产业最大份额

报告还根据应用程式类型提供了详细的市场细分和分析。这包括美学和治疗学。报告显示，美容占据了最大的市场。

美容部分包括改善脸部整体外观和解决老化迹象的整容手术。随着注射技术支援的美容文化的兴起，为患者提供安全有效的微创治疗成为可能，越来越多的人选择接受此类手术。根据美国整形外科医生协会 (ASPS) 的数据，整容手术增加了 8%。国际美容整形外科学会2022年进行的调查结果显示，美容手术呈现持续成长趋势，近四年大幅增加41.3%。因此，脸部除皱手术的增加促进了脸部注射剂市场的成长。

按应用划分：

脸部线条矫正

丰唇术

脸部提升

痤疮疤痕治疗

其他的

该报告根据应用程式提供了详细的市场细分和分析。这包括脸部线条矫正、丰唇、脸部提升、痤疮疤痕治疗等。

脸部注射通常用于矫正脸部皮肤的细纹、皱纹和深层皱纹，让患者看起来更清新、更光滑。适用区域包括前额、眼部鱼尾纹、法令纹等，确保自然效果，赋予脸部年轻曲线。

注射填充剂也可用于丰唇，以增加唇部尺寸、赋予其形状并保持与脸部的和谐比例。有时，患者会使用填充剂来获得更饱满的外观，纠正因老化而造成的口红皱纹，或改善嘴唇的形状和比例。根据国际美容整形外科学会 (ISAPS) 的数据，2022 年抽脂手术是最常见的外科手术，手术量超过 230 万例，增加了 21.1%。

此外，填充剂可以以非侵入性的方式重现与手术类似的效果。这只是脸部任何区域的体积增加，导致下巴、脸颊或太阳穴区域出现缺陷并随后下垂。填充注射剂可以使脸部外观提拉、恢復活力，同时降低术后併发症的风险并加快患者的恢復时间。除此之外，注射填充剂也用于纠正凹陷性痤疮疤痕并恢復许多人的信心。

按最终用户划分：

医院

皮肤科诊所

其他的

医院在市场上表现出明显的主导地位

报告还提供了基于最终用户的详细市场细分和分析。这包括医院、皮肤科诊所等。报告显示，医院占据了最大的市场。

该医院经常充当各种医疗和美容手术的一站式场所，为脸部注射提供便利。由于医院的便利性和可信度，这些机构吸引了广泛的患者。寻求专业护理和技能的患者可以轻鬆地在医院获得服务。国际美容整形外科学会 (ISAPS) 的一份报告显示，2022 年整形外科医生实施的手术总数为 11.2%，其中涉及全球 1,490 万例手术和 1,880 万例非手术程序。随着人们接受手术修復程序，医院满足了许多人对美容治疗的需求，从而产生了脸部注射剂市场收入。医院拥有充足且先进的工具以及训练有素的专业人员来进行脸部注射。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美市场领先，占据最大的脸部注射市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是脸部注射剂最大的区域市场。

根据脸部注射剂市场研究，北美由于多种原因主导市场，导致其强劲成长。这主要是由于大量老龄化人口、高可支配收入、先进的医疗设施以及一些人保持年轻和美丽的压力。此外，主要参与者的持续创新和技术进步维持了市场的扩张。 2023 年 5 月，Evolus, Inc. 是一家为消费者提供具有卓越体验的创新产品的功能性美容组织，在美国签订了五种处于高级开发阶段的新型真皮填充剂的独家经销协议。

竞争格局：

脸部注射剂市场研究报告也对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。脸部注射剂产业的一些主要市场参与者包括 Allergan Plc、Anika Therapeutics Inc.、Bloomage BioTechnology、Johnson & Johnson、Galderma Pharma SA、Integra LifeSciences、Ipsen (Mayroy SA)、Medytox Inc.、Merz Holding GmbH & Co.。 、Prollenium Medical Technologies Inc.、赛诺菲、SciVision Biotech Inc.、Sinclair Pharma（华东医药股份有限公司）、Suneva Medical Inc. 和Bausch Health Companies Inc.

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

脸部注射剂市场的主要参与者正在采取重要措施以确保该行业的成长。因此，艾尔建 (Allergan)、高德美 (Galderma)、隆泰 (Longtai) 和辛克莱 (Sinclair) 等公司透过开发新配方确保了自己拥有广泛的产品组合。他们还透过与医疗器材公司签订协议和建立合作伙伴关係来扩大市场范围。促销计划将有助于提高消费者对使用脸部注射剂好处的认识，从而使注射剂子行业受益。例如，Galderma 在达拉斯推出了FACE by Galderma(TM)，将其设想为一种由增强现实(AR) 驱动的先进美容可视化工具，这项创新倡议使美容专家和患者能够在手术前预测注射治疗的结果。 Galderma 旨在提供每根针头所能达到的范围的模拟前后影像，并有望减轻患者对注射结果的焦虑。

脸部注射剂市场新闻：

2024 年3 月：艾伯维(AbbVie) 旗下公司Allergan Aesthetics 宣布，美国食品药物管理局(FDA) 已批准JUVEDERM(R) VOLUMA(R) XC 透明质酸(HA) 填充剂注射到一名中度至中度患者的太阳穴中21 岁以上成年人严重的太阳穴空洞。

2023年10月：华东医药股份有限公司全资子公司Sinclair Pharma Details宣布与ATGC Pharmacological Research结成策略伙伴关係，建立合理的许可安排。 Sinclair 已获得生产和商业化 ATGC 肉毒毒素产品 ATGC-110 的独家权利，ATGC-110 是尖端 A 型肉毒毒素，正在进行临床开发，用于暂时增强中度至重度眉间外观。它已获得全球独家授权（不包括印度和韩国）。

本报告回答的关键问题

  • 全球脸部注射剂市场成长如何
  • 全球脸部注射剂市场驱动因素是什么
  • 全球脸部注射剂市场的主要行业趋势是什么
  • COVID-19对全球脸部注射剂市场有何影响
  • 全球脸部注射剂市场按产品类型划分是怎样的
  • 全球脸部注射剂市场按应用类型划分是怎样的
  • 全球脸部注射剂市场最终用户的细分如何
  • 全球脸部注射剂市场主要有哪些地区
  • 全球脸部注射剂市场的主要公司/参与者有哪些

本报告回答的关键问题

  • 全球脸部注射剂市场成长情况如何？全球脸部注射剂市场驱动因素是什么？
  • 全球脸部注射剂市场的主要行业趋势是什么？
  • COVID-19 对全球脸部注射剂市场有何影响？
  • 按产品类型分類的全球脸部注射剂市场细分是多少？
  • 全球脸部注射剂市场按应用类型划分是怎样的？
  • 全球脸部注射剂市场最终用户的细分情况如何？
  • 全球脸部注射剂市场的主要地区有哪些？
  • 全球脸部注射剂市场的主要公司/参与者有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球脸部注射剂市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • 胶原
    • 市场趋势
    • 市场预测
  • 透明质酸 (HA)
    • 市场趋势
    • 市场预测
  • A型肉毒桿菌毒素
    • 市场趋势
    • 市场预测
  • 羟基磷灰石钙 (CaHA)
    • 市场趋势
    • 市场预测
  • 聚甲基丙烯酸甲酯珠（PMMA微球）
    • 市场趋势
    • 市场预测
  • 聚左旋乳酸 (PLLA)
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按应用类型

  • 美学
    • 市场趋势
    • 市场预测
  • 疗法
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按应用

  • 脸部线条矫正
    • 市场趋势
    • 市场预测
  • 丰唇术
    • 市场趋势
    • 市场预测
  • 脸部提升
    • 市场趋势
    • 市场预测
  • 痤疮疤痕治疗
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院
    • 市场趋势
    • 市场预测
  • 皮肤科诊所
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Allergan Plc
    • Anika Therapeutics Inc.
    • Bloomage BioTechnology
    • Johnson & Johnson
    • Galderma Pharma SA
    • Integra LifeSciences
    • Ipsen (Mayroy SA)
    • Medytox Inc.
    • Merz Holding GmbH & Co. KG
    • Prollenium Medical Technologies Inc.
    • Sanofi
    • SciVision Biotech Inc.
    • Sinclair Pharma (Huadong Medicine Co. Ltd.)
    • Suneva Medical Inc.
    • Bausch Health Companies Inc.
Product Code: SR112024A2814

The global facial injectables market size reached US$ 8.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.7 Billion by 2032, exhibiting a growth rate (CAGR) of 8.3% during 2024-2032. The facial injectables market is driven by the growing aging population, and the increasing demand for non-invasive solutions among individuals, and celebrity endorsements and social media influence driving demand for aesthetic treatments worldwide.

Facial Injectables Market Analysis:

Major Market Drivers: The market growth is propelled by the increasing demand for minimally invasive cosmetic procedures, increasing awareness of facial aesthetics, and the desire of the aging population to appear youthful.

Key Market Trends: The demand for non-surgical procedures such as Botox and dermal fillers is increasing as a result of their efficiency and minimal level of downtime. In the facial injectables market forecast, the industry will witness the ongoing creation of diverse product formulations and application options influenced by the increased desire to attain natural-looking results and to offer patients treatments that are effective safe customized.

Geographical Trends: North America is the largest market due to high disposable income, well-developed healthcare infrastructure, and widespread adoption of aesthetic treatments. Other potential markets include Asia-Pacific and Europe, where residents' income is increasing, followed by stringent regulations, and hundreds of aesthetic clinics providing injectable treatment.

Competitive Landscape: Some of the major market players in the facial injectables industry include Allergan Plc, Anika Therapeutics Inc., Bloomage BioTechnology, Johnson & Johnson, Galderma Pharma S.A., Integra LifeSciences, Ipsen (Mayroy SA), Medytox Inc., Merz Holding GmbH & Co. KG, Prollenium Medical Technologies Inc., Sanofi, SciVision Biotech Inc., Sinclair Pharma (Huadong Medicine Co. Ltd.), Suneva Medical Inc. and Bausch Health Companies Inc. among many others.

Challenges and Opportunities: The regulatory hurdles and safety concerns pose challenges for market players, necessitating stringent compliance with quality standards and transparent communication with consumers. As outlined in the facial injectables market overview, eexpansion into untapped markets, such as emerging economies and male aesthetic procedures, offers avenues for growth amidst intensifying competition and market saturation in traditional segments.

Facial Injectables Market Trends:

Increasing Aging Population:

As the global population is aging the demand for facial injectables is rising. While they are essential, aging comes with various visible signs like wrinkles, fine lines, and sagging skin. Thus, individuals always opt for aesthetic treatments to keep a youthful appearance. Due to the zero downtime and non-surgical procedure, facial injectables encourage a wide audience inquiring about self-rejuvenation without undergoing invasive treatments. Furthermore, the age sector in developed countries is expanding, and people now care more about their appearance. Hence, they are willing to seek aesthetic treatments to look and feel their best, influencing the facial injectables market outlook. In 2020, the global population aged 60 years and above exceeded the under-five children, according to the World Health Organization. The aging population is expected to double globally from 12% in 2015 to 22% in 2050.

Rising Demand for Non-Invasive Procedures

Individuals are opting for non-invasive facial plastic procedures owing to their convenience, minimal downtime decreased risk, and fewer side effects. For example, dermal fillers and botulinum toxin injections, are injectables that provide quick and efficient solutions to numerous common aesthetic problems like wrinkles, volume depletion, and facial asymmetry. Moreover, busy lives, and technological advances that make many procedures efficient and less dangerous, influence the new generation of non-invasive face treatments, which is increasing the facial injectables market value. Data from the American Society of Plastic Surgeons (ASPS) reveals that a total of 26.2 million surgical and minimally invasive cosmetic and reconstructive treatments were performed in the United States in 2022. It also reveals that 19% of cosmetic surgeries surged since 2019, increasing the facial injectables market demand.

Celebrity Endorsements and Social Media Influence

Beauty standards and consumer preferences are influenced by celebrity endorsements and social media personalities which is driving the facial injectables market growth. When celebrities openly discuss their facial plastic surgeries or post about them on various social media sites, their followers are more likely to consider using facial injectables. For instance, according to the survey by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), facial plastic surgeons have reported a 90% rise in facelifts since 2019. Last year, facelifts were the leading surgical procedure for females, with 86% of surgeons performing them. Noses jobs or rhinoplasty come second, with surgeons performing them on 79%, while blepharoplasty or eye lift stood at 73%. For both genders, the top three surgical procedures are rhinoplasty accounting for 83%, blepharoplasties at 49%, and facelifts and partial facelifting at 48%.

Facial Injectables Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, application type, application, and end user.

Breakup by Product Type:

Collagen

Hyaluronic Acid (HA)

Botulinum Toxin Type A

Calcium Hydroxylapatite (CaHA)

Polymethylmethacrylate Beads (PMMA Microspheres)

Poly-L-Lactic Acid (PLLA)

Others

Botulinum toxin type A accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes collagen, hyaluronic acid (HA), botulinum toxin type A, calcium hydroxylapatite (CaHA), polymethylmethacrylate beads (PMMA microspheres), poly-l-lactic acid (PLLA), and others. According to the report, botulinum toxin type A represented the largest segment.

Botulinum toxin type A comprises the largest segment due to its wide use to address several cosmetic concerns, including wrinkles, fine lines, and facial asymmetry. Botulinum toxin type A injections, such as Botox, Dysport, and Xeomin, provide a sophisticated, temporary solution by relaxing facial muscles and ensuring smoother and younger-looking skin. Currently, consumer demand for minimally invasive cosmetic procedures continues to rise driving the production of existing product lines. For example, in March 2024, Croma's Korean toxin product manufacturer and partner Hugel was approved by the U.S. Food and Drug Administration for Letybo(R) (LetibotulinumtoxinA) to treat glabellar lines in adults.

Breakup by Application Type:

Aesthetics

Therapeutics

Aesthetics holds the largest share of the industry

A detailed breakup and analysis of the market based on the application type have also been provided in the report. This includes aesthetics and therapeutics. According to the report, aesthetics accounted for the largest market share.

The aesthetic segment includes cosmetic procedures to improve the overall appearance of the face and address signs of aging. With the rise of beauty cultures supported by injectable technologies, which made it possible to offer safe and effective minimally invasive treatments to the patient, more people have opted to undergo such procedures. As per the American Society of Plastic Surgeons (ASPS), facelifts grew by 8%. The survey conducted in 2022 by the International Society of Aesthetic Plastic Surgery presents such results that the trends showed a continued increase in aesthetic surgery, with a significant increase of 41.3% in the last four years. As a result, the increasing facelift procedures are contributing to the facial injectables market growth.

Breakup by Application:

Facial Line Correction

Lip Augmentation

Face Lift

Acne Scar Treatment

Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes facial line correction, lip augmentation, face lift, acne scar treatment, and others.

Facial injectables are commonly used for correcting fine lines, wrinkles, and deep creases in the facial skin to give the patient a fresher and smoother look. Areas of application include the forehead, crow's feet in the eye region, and nasolabial folds, among others, ensuring a natural result that gives the face its youthful curves.

Injectable fillers are also used in lip augmentation to increase the size, give it shape, and maintain a harmonic proportion with the face. Sometimes patients use fillers to get a fuller look, to correct lipstick creases due to aging, or to give better shape and proportion to the lip. Liposuction was the most common surgical procedure according to the International Society of Aesthetic Plastic Surgery (ISAPS) in 2022, with more than 2.3 million procedures and a 21.1% expansion.

Additionally, fillers can recreate a similar effect as surgery in a non-invasive way. This simply an increase in volume in any area of the face that has undergone a deficit and subsequent sagging in the jaw, cheek, or temple areas. Filler injectables result in a lifted and rejuvenated appearance of the face at a reduced risk of postoperative complications and a faster recovery time for the patient. Besides this, injectable fillers are also used in correcting depressed acne scars and restoring the confidence of numerous individuals.

Breakup by End User:

Hospitals

Dermatology Clinics

Others

Hospitals exhibit a clear dominance in the market

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, dermatology clinics, and others. According to the report, hospitals accounted for the largest market share.

The hospital often acts as a one stop space for various medical and cosmetic procedures, facilitating facial injectables among their services. As a result of accessibility and the credibility associated with hospitals, the institutions have attracted a broad patient spectrum. Patients seeking professional care and skills easily obtain their services at a hospital. One report by the International Society of Aesthetic Plastic Surgery (ISAPS) indicated an overall 11.2% of procedures performed by plastic surgeons in 2022, involving 14.9 million surgical and 18.8 million non-surgical procedures performed all over the world. As people embrace surgery restoration procedures the hospital helps numerous individuals' needs for aesthetic treatments, thus generating facial injectables market revenue. Hospitals have adequate and sophisticated tools and well-trained professionals to administer facial injectables.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest facial injectables market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for facial injectables.

As per the facial injectables market research, North America is dominating the market for several reasons resulting in its strong growth. This is mainly due to a large aging population, high disposable income, advanced healthcare facilities, and the pressure to remain young and beautiful among several individuals. Moreover, continuous innovation and technological advancements by key players have sustained the market expansion. In May 2023, Evolus, Inc., a performance beauty organization that delivers innovative products with exceptional experiences to consumers, entered into an exclusive distribution agreement in the United States for five novel dermal fillers with advanced stages of development.

Competitive Landscape:

The facial injectables market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the facial injectables industry include Allergan Plc, Anika Therapeutics Inc., Bloomage BioTechnology, Johnson & Johnson, Galderma Pharma S.A., Integra LifeSciences, Ipsen (Mayroy SA), Medytox Inc., Merz Holding GmbH & Co. KG, Prollenium Medical Technologies Inc., Sanofi, SciVision Biotech Inc., Sinclair Pharma (Huadong Medicine Co. Ltd.), Suneva Medical Inc. and Bausch Health Companies Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key players in the facial injectables market are taking vital steps to ensure the growth of the sector. As a result, companies such as Allergan, Galderma, Longtai, and Sinclair have ensured they have an extensive product portfolio by developing new formulations. They are also expanding their market reach by entering into agreements and partnerships with medical device companies. The promotional programs will help increase consumer awareness about the benefits of using facial injectables, benefiting the injectables sub-sector. For instance, Galderma, launched FACE by Galderma(TM) in Dallas envisioning it as an advanced aesthetic visualization tool driven by augmented reality (AR), the inventive initiative enables aesthetic experts and patients to foretell injectable treatment results even before the procedure. Galderma aims to provide a simulated before and after image of what the scope of each needle can achieve and hopefully alleviate patient anxieties concerning injectable outcomes.

Facial Injectables Market News:

March 2024: Allergan Aesthetics, an AbbVie company, announced that the U.S. FOOD and DRUG ADMINISTRATION (FDA) had approved JUVEDERM(R) VOLUMA(R) XC hyaluronic acid (HA) filler to inject into the temple of a patient identified for moderate to severe temple hollowing in adults over the age of 21. This is the sole HA filler that the FDA has authorized with optimal treatment that is clinically documented to endure up to 13 months.

October 2023: Sinclair Pharma Details, a wholly owned subsidiary of Huadong Medicine Co., Ltd., declared the formation of a strategic partnership with ATGC Pharmacological Research to establish a rational licensing arrangement. Sinclair has been granted exclusive rights to manufacture and commercialize ATGC's botulinum toxin product, ATGC-110, cutting-edge botulinum toxin type A, undergoing clinical development for temporarily enhanced glabellar appearances at moderate to severe levels. It has been exclusively licensed globally (excluding India and South Korea).

Key Questions Answered in This Report

  • 1. What is the global facial injectables market growth?
  • 2. What are the global facial injectables market drivers?
  • 3. What are the key industry trends in the global facial injectables market?
  • 4. What is the impact of COVID-19 on the global facial injectables market?
  • 5. What is the global facial injectables market breakup by product type?
  • 6. What is the global facial injectables market breakup by application type?
  • 7. What is the global facial injectables market breakup by end user?
  • 8. What are the major regions in the global facial injectables market?
  • 9. Who are the key companies/players in the global facial injectables market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Facial Injectables Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Collagen
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hyaluronic Acid (HA)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Botulinum Toxin Type A
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Calcium Hydroxylapatite (CaHA)
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Polymethylmethacrylate Beads (PMMA Microspheres)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Poly-L-Lactic Acid (PLLA)
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Application Type

  • 7.1 Aesthetics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Therapeutics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Facial Line Correction
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Lip Augmentation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Face Lift
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Acne Scar Treatment
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Dermatology Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Allergan Plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Anika Therapeutics Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Bloomage BioTechnology
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Johnson & Johnson
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Galderma Pharma S.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Integra LifeSciences
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Ipsen (Mayroy SA)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Medytox Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Merz Holding GmbH & Co. KG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Prollenium Medical Technologies Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Sanofi
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 SciVision Biotech Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
    • 15.3.13 Sinclair Pharma (Huadong Medicine Co. Ltd.)
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
    • 15.3.14 Suneva Medical Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
    • 15.3.15 Bausch Health Companies Inc.
      • 15.3.15.1 Company Overview
      • 15.3.15.2 Product Portfolio
      • 15.3.15.3 Financials
      • 15.3.15.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Facial Injectables Market: Major Drivers and Challenges
  • Figure 2: Global: Facial Injectables Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Facial Injectables Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Facial Injectables Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Facial Injectables Market: Breakup by Application Type (in %), 2023
  • Figure 6: Global: Facial Injectables Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Facial Injectables Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Facial Injectables Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Facial Injectables (Collagen) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Facial Injectables (Collagen) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Facial Injectables (Hyaluronic Acid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Facial Injectables (Hyaluronic Acid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Facial Injectables (Botulinum Toxin Type A) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Facial Injectables (Botulinum Toxin Type A) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Facial Injectables (Calcium Hydroxylapatite) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Facial Injectables (Calcium Hydroxylapatite) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Facial Injectables (Polymethylmethacrylate Beads) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Facial Injectables (Polymethylmethacrylate Beads) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Facial Injectables (Poly-L-Lactic Acid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Facial Injectables (Poly-L-Lactic Acid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Facial Injectables (Other Product Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Facial Injectables (Other Product Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Facial Injectables (Aesthetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Facial Injectables (Aesthetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Facial Injectables (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Facial Injectables (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Facial Injectables (Facial Line Correction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Facial Injectables (Facial Line Correction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Facial Injectables (Lip Augmentation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Facial Injectables (Lip Augmentation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Facial Injectables (Face Lift) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Facial Injectables (Face Lift) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Facial Injectables (Acne Scar Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Facial Injectables (Acne Scar Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Facial Injectables (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Facial Injectables (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Facial Injectables (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Facial Injectables (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Facial Injectables (Dermatology Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Facial Injectables (Dermatology Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Facial Injectables (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Facial Injectables (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: North America: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: North America: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: United States: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: United States: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Canada: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Canada: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Asia-Pacific: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Asia-Pacific: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: China: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: China: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Japan: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Japan: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: India: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: India: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: South Korea: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: South Korea: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Australia: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Australia: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Indonesia: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Indonesia: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Europe: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Europe: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Germany: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Germany: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: France: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: France: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: United Kingdom: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: United Kingdom: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Italy: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Italy: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Spain: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Spain: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Russia: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Russia: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Latin America: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Latin America: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Brazil: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Brazil: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Mexico: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Mexico: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Others: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Others: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Middle East and Africa: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Middle East and Africa: Facial Injectables Market: Breakup by Country (in %), 2023
  • Figure 91: Middle East and Africa: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Global: Facial Injectables Industry: SWOT Analysis
  • Figure 93: Global: Facial Injectables Industry: Value Chain Analysis
  • Figure 94: Global: Facial Injectables Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Facial Injectables Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Facial Injectables Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Facial Injectables Market Forecast: Breakup by Application Type (in Million US$), 2024-2032
  • Table 4: Global: Facial Injectables Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Facial Injectables Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Facial Injectables Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Facial Injectables Market Structure
  • Table 8: Global: Facial Injectables Market: Key Players